---
layout: post
title: "Advisory Committee; Genetic Metabolic Diseases Advisory Committee; Establishment"
date: 2026-02-05 18:57:54 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-27304
original_published: 2023-12-13 00:00:00 +0000
significance: 8.00
---

# Advisory Committee; Genetic Metabolic Diseases Advisory Committee; Establishment

**Published:** February 05, 2026 18:57 UTC
**Source:** Federal Register
**Original Published:** December 13, 2023 00:00 UTC
**Document Number:** 2023-27304

## Summary

Under the Federal Advisory Committee Act, the Food and Drug Administration (FDA) is announcing the establishment of the Genetic Metabolic Diseases Advisory Committee. The Commissioner of Food and Drugs (Commissioner) has determined that it is in the public interest to establish such a committee. Duration of this committee is 2 years from the date the Charter is filed, unless the Commissioner formally determines that renewal is in the public interest.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/12/13/2023-27304/advisory-committee-genetic-metabolic-diseases-advisory-committee-establishment)
- API: https://www.federalregister.gov/api/v1/documents/2023-27304

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
